# TYRUKO
> **BLA761322** · Biologics License Application · Sponsor: SANDOZ INC · Approved 2023-08-24
## Drug
- **FDA Application Number:** BLA761322
- **Application type:** Biologics License Application
- **Brand name:** TYRUKO
- **Generic name:** NATALIZUMAB-SZTN
- **Active ingredients:** NATALIZUMAB-SZTN
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SANDOZ INC
- **Manufacturer:** Sandoz Inc
- **First approval:** 2023-08-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761322)
---
*MORVS · CC0 1.0*